Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00687908 · ClinicalTrials.gov registry record · Phase 3
Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance
A Phase 3 study, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 3
- Development phase
- 243
- Enrollment target
NCT00687908 is a Phase 3 study that has completed, run by Galderma R&D. The registered enrollment target is 243 participants.
The verdict
NCT00687908, a Phase 3 study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 243 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the efficacy of Adapalene 0.1% /Benzoyl Peroxide 2.5% Gel compared to its Vehicle Gel as an acne maintenance treatment in Subjects previously treated with Adapalene-BPO Gel or Adapalene-BPO Vehicle Gel both associated with Doxycycline Hyclate 100 mg. The safety of the two investigational treatments will also be assessed.
Interventions
- DRUG Vehicle Gel
- DRUG Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 243 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00687908
The ClinicalTrials.gov registry entry for NCT00687908 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 243 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle Gel is the first listed.
NCT00687908 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00687908 about?
NCT00687908 is a clinical study titled "Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance". The purpose of this study is to demonstrate the efficacy of Adapalene 0.1% /Benzoyl Peroxide 2.5% Gel compared to its Vehicle Gel as an acne maintenance treatment in Subjects previously treated with Adapalene-BPO Gel or Adapalene-BPO Vehicle Gel both associated with Doxycycline Hyclate 100 mg. The s...
What is the current status of trial NCT00687908?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 243 participants. The study started on 2008-11. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00687908?
The interventions under investigation include: Vehicle Gel (DRUG), Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel (DRUG).
Who is sponsoring clinical trial NCT00687908?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.